Pricing
Login
Home
Charts
Search
Watchlist
Products

Sanjivani Paranteral Ltd

SANJIVIN
₹167.10-3.44%20 Nov 2026
Reports
Pharma Formulations

Sanjivani Paranteral Ltd

SANJIVIN
₹167.10
-3.44%
20 Nov 2026
Ask AI
6M
Price
Charts
Documents

Quick Ratios

Edit Ratios
Mkt Cap
Market Capitalization
₹205Cr
Close
Close Price
₹167.10
Industry
Industry
Pharma Formulations
PE
Price To Earnings
20.60
PS
Price To Sales
2.43
Revenue
Revenue
₹84Cr
Rev Gr TTM
Revenue Growth TTM
22.52%
PAT Gr TTM
PAT Growth TTM
33.65%

Quarterly Results

Consolidated
Standalone
Numbers
Percentage
QuarterDec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026
Revenue
RevenueCr
151316181718181622132425
Growth YoY
Revenue Growth YoY%
16.041.48.8-14.527.1-27.333.363.4
Expenses
ExpensesCr
131114151516151318122019
Operating Profit
Operating ProfitCr
222333324246
OPM
OPM%
13.116.814.215.814.714.414.814.517.412.017.525.6
Other Income
Other IncomeCr
000000000100
Interest Expense
Interest ExpenseCr
000000000000
Depreciation
DepreciationCr
000000000111
PBT
PBTCr
222333224136
Tax
TaxCr
011110111111
PAT
PATCr
212222223124
Growth YoY
PAT Growth YoY%
15.273.81.2-28.746.3-74.943.9153.1
NPM
NPM%
11.09.810.412.710.912.19.710.612.64.210.416.4
EPS
EPS₹
1.61.11.52.01.61.81.51.32.20.52.03.4
QuarterDec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026
Revenue
RevenueCr
151316181718181622132425
Growth YoY
Revenue Growth YoY%
16.041.48.8-14.527.1-27.333.363.4
Expenses
ExpensesCr
131114151516151318122019
Operating Profit
Operating ProfitCr
222333324246
OPM
OPM%
13.116.814.215.814.714.414.814.517.412.017.525.6
Other Income
Other IncomeCr
000000000100
Interest Expense
Interest ExpenseCr
000000000000
Depreciation
DepreciationCr
000000000111
PBT
PBTCr
222333224136
Tax
TaxCr
011110111111
PAT
PATCr
212222223124
Growth YoY
PAT Growth YoY%
15.273.81.2-28.746.3-74.943.9153.1
NPM
NPM%
11.09.810.412.710.912.19.710.612.64.210.416.4
EPS
EPS₹
1.61.11.52.01.61.81.51.32.20.52.03.4

Profit & Loss

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2024Mar 2025Mar 2026TTM
Revenue
RevenueCr
54706984
Growth
Revenue Growth%
28.8-2.022.5
Expenses
ExpensesCr
46605968
Operating Profit
Operating ProfitCr
8101016
OPM
OPM%
15.214.814.819.0
Other Income
Other IncomeCr
1111
Interest Expense
Interest ExpenseCr
0111
Depreciation
DepreciationCr
1112
PBT
PBTCr
810914
Tax
TaxCr
1234
PAT
PATCr
68710
Growth
PAT Growth%
31.3-17.333.6
NPM
NPM%
11.311.69.811.8
EPS
EPS₹
5.36.95.58.1
Financial YearMar 2024Mar 2025Mar 2026TTM
Revenue
RevenueCr
54706984
Growth
Revenue Growth%
28.8-2.022.5
Expenses
ExpensesCr
46605968
Operating Profit
Operating ProfitCr
8101016
OPM
OPM%
15.214.814.819.0
Other Income
Other IncomeCr
1111
Interest Expense
Interest ExpenseCr
0111
Depreciation
DepreciationCr
1112
PBT
PBTCr
810914
Tax
TaxCr
1234
PAT
PATCr
68710
Growth
PAT Growth%
31.3-17.333.6
NPM
NPM%
11.311.69.811.8
EPS
EPS₹
5.36.95.58.1
Sales CAGR
1 Year-2%
3 Years-
5 Years-
TTM23%
EBITDA CAGR
1 Year-2%
3 Years-
5 Years-
TTM60%
PAT CAGR
1 Year-17%
3 Years-
5 Years-
TTM34%
Avg. ROCE
1 Year16%
3 Years23%
5 Years-
TTM21%
CFO / EBITDA
1 Year-1%
3 Years6%
5 Years-
TTM-

Balance Sheet

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2024Mar 2025Mar 2026Sep 2026
Equity Capital
Equity CapitalCr
12121212
Reserves
ReservesCr
14253642
Current Liabilities
Current LiabilitiesCr
14322619
Non Current Liabilities
Non Current LiabilitiesCr
271115
Total Liabilities
Total LiabilitiesCr
43788892
Current Assets
Current AssetsCr
29343642
Non Current Assets
Non Current AssetsCr
15445250
Total Assets
Total AssetsCr
43788892
Financial YearMar 2024Mar 2025Mar 2026Sep 2026
Equity Capital
Equity CapitalCr
12121212
Reserves
ReservesCr
14253642
Current Liabilities
Current LiabilitiesCr
14322619
Non Current Liabilities
Non Current LiabilitiesCr
271115
Total Liabilities
Total LiabilitiesCr
43788892
Current Assets
Current AssetsCr
29343642
Non Current Assets
Non Current AssetsCr
15445250
Total Assets
Total AssetsCr
43788892

Cash Flow

Consolidated
Standalone
Financial YearMar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
-11120
Investing Cash Flow
Investing Cash FlowCr
-12-22-10
Financing Cash Flow
Financing Cash FlowCr
231010
Net Cash Flow
Net Cash FlowCr
010
Free Cash Flow
Free Cash FlowCr
-14-18-9
CFO To PAT
CFO To PAT%
-173.6153.2-1.7
CFO To EBITDA
CFO To EBITDA%
-129.9119.8-1.1
Financial YearMar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
-11120
Investing Cash Flow
Investing Cash FlowCr
-12-22-10
Financing Cash Flow
Financing Cash FlowCr
231010
Net Cash Flow
Net Cash FlowCr
010
Free Cash Flow
Free Cash FlowCr
-14-18-9
CFO To PAT
CFO To PAT%
-173.6153.2-1.7
CFO To EBITDA
CFO To EBITDA%
-129.9119.8-1.1

Ratios

Consolidated
Standalone
Financial YearMar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
175285163205
Price To Earnings
Price To Earnings
28.435.224.420.6
Price To Sales
Price To Sales
3.24.12.42.4
Price To Book
Price To Book
6.87.83.43.8
EV To EBITDA
EV To EBITDA
20.228.117.313.6
Profitability Ratios
Profitability Ratios
GPM
GPM%
39.836.831.331.3
OPM
OPM%
15.214.814.819.0
NPM
NPM%
11.311.69.811.8
ROCE
ROCE%
29.124.416.121.3
ROE
ROE%
23.822.113.918.4
ROA
ROA%
14.210.37.610.9
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Financial YearMar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
175285163205
Price To Earnings
Price To Earnings
28.435.224.420.6
Price To Sales
Price To Sales
3.24.12.42.4
Price To Book
Price To Book
6.87.83.43.8
EV To EBITDA
EV To EBITDA
20.228.117.313.6
Profitability Ratios
Profitability Ratios
GPM
GPM%
39.836.831.331.3
OPM
OPM%
15.214.814.819.0
NPM
NPM%
11.311.69.811.8
ROCE
ROCE%
29.124.416.121.3
ROE
ROE%
23.822.113.918.4
ROA
ROA%
14.210.37.610.9
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Market CapitalizationMkt CapCr233233232205202198177
Close PriceClose₹38.16404.00320.00167.10160.7067.20161.70
IndustryIndustryPharma FormulationsPharma FormulationsPharma FormulationsPharma FormulationsPharma FormulationsPharma FormulationsPharma Formulations
Price To EarningsPE20.4528.9320.600.282.7233.41
Price To SalesPS5.752.294.732.433.122.516.98
RevenueRevenueCr411014984657925
Revenue Growth TTMRev Gr TTM%-8.4%41.8%96.6%22.5%-14.9%3.4%
PAT Growth TTMPAT Gr TTM%-238.4%16.6%83.2%33.6%421.4%-29.6%
Market CapitalizationMkt CapCr233233232205202198177
Close PriceClose₹38.16404.00320.00167.10160.7067.20161.70
IndustryIndustryPharma FormulationsPharma FormulationsPharma FormulationsPharma FormulationsPharma FormulationsPharma FormulationsPharma Formulations
Price To EarningsPE20.4528.9320.600.282.7233.41
Price To SalesPS5.752.294.732.433.122.516.98
RevenueRevenueCr411014984657925
Revenue Growth TTMRev Gr TTM%-8.4%41.8%96.6%22.5%-14.9%3.4%
PAT Growth TTMPAT Gr TTM%-238.4%16.6%83.2%33.6%421.4%-29.6%
Annual Reports
FY2026
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
Quarterly Reports
FY2026
Sep 26
ResultPPT
Transcript
Summary
Jun 26
ResultPPT
Transcript
Summary
Sep 23
ResultPPT
Transcript
Summary
Mar 23
ResultPPT
Transcript
Summary
Dec 22
ResultPPT
Transcript
Summary
Sep 22
Result
PPT
Transcript
Summary
Jun 22
Result
PPT
Transcript
Summary
Mar 22
Result
PPT
Transcript
Summary
Sep 21
Result
PPT
Transcript
Summary
Mar 21
Result
PPT
Transcript
Summary
Sep 20
Result
PPT
Transcript
Summary
Annual Reports
Quarterly Reports
Sep 26
ResultPPT
Transcript
Summary
Jun 26
ResultPPT
Transcript
Summary
Sep 23
ResultPPT
Transcript
Summary
Mar 23
ResultPPT
Transcript
Summary
Dec 22
ResultPPT
Transcript
Summary
Sep 22
Result
PPT
Transcript
Summary
Jun 22
Result
PPT
Transcript
Summary
Mar 22
Result
PPT
Transcript
Summary
Sep 21
Result
PPT
Transcript
Summary
Mar 21
Result
PPT
Transcript
Summary
Sep 20
Result
PPT
Transcript
Summary
Load More
Interviews